• 1
    Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit? Diabetes Care 2004; 27: 10111012.
  • 2
    Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51: 931938.
  • 3
    Grundy SM. Point: the metabolic syndrome still lives. Clin Chem 2005; 51: 13521354.
  • 4
    Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 22892304.
  • 5
    Gale EAM. The myth of the metabolic syndrome. Diabetologia 2005; 48: 16791683.
  • 6
    Hitzenberger K, Richter-Quittner M. Ein Beitrag zum Stoffwechsel bei der vaskulären Hypertonie. Wiener Arch Innere Med 1921; 2: 189216.
  • 7
    Kylin E. Studien über das Hypertonie-Hyperglykämie-Hyperurikämisyndrom. Zeitschrift f. Innere Med 1923; 7: 105112.
  • 8
    Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 15951607.
  • 9
    Cheal KL, Abbasi F, Lamendola C, Mclaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004; 53: 11951200.
  • 10
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539553.
  • 11
    Alberti KGMM, Zimmet P, Shaw J for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet 2005; 366: 10591062.
  • 12
    National Cholesterol Education Program (NCEP). The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 24862497.
  • 13
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Executive Summary Circulation 2005; 112: 27352752.
  • 14
    Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683689.
  • 15
    Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 2002; 288: 27092716.
  • 16
    Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, Decode Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 2004; 164: 10661076.
  • 17
    Mcneill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385390.
  • 18
    Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 17691778.
  • 19
    Lawlor DA, Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2005; 49: 18.
  • 20
    Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 27452749.
  • 21
    Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 11571159.
  • 22
    The Decode Study Group, Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006; 49: 28372846.
  • 23
    Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001; 10: 489499.
  • 24
    Hedblad B, Nilsson P, Engström G, Janzon L, Berglund G. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002; 19: 470475.
  • 25
    Taylor HL, Jacobs D, Schuker B, Knudsen J, Leon A, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chron Dis 1978; 31: 741755.
  • 26
    Callmer E, Riboli E, Saracci R, Åkesson B, Lindgärde F. Dietary assessment methods evaluated in the Malmö food study. J Intern Med 1993; 233: 5357.
  • 27
    Royal College of Psychiatrists. Alcohol: Our Favourite Drug. London: Tavistock, 1986.
  • 28
    Thorell JI, Larson SM. Radioimmunoassey and Related Techniques. St Louis: CV Mosby Company, 1978: 205211.
  • 29
    Burstein M, Scholnik H, Morfin R. Rapid method for the isolation of proteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583595.
  • 30
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 31
    Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442443..
  • 32
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412419..
  • 33
    Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001; 48: 8186.
  • 34
    Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 18371847.
  • 35
    Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460468.
  • 36
    Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006; 29: 901907.
  • 37
    Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404409.
  • 38
    Jonsson S, Hedblad B, Engström G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22 025 men from an urban Swedish population. Int J Obes Relat Metab Disord 2002; 26: 10461053.
  • 39
    Thomas F, Bean K, Pannier B, Oppert JM, Guize L, Benetos A. Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension 2005; 46: 654659.
  • 40
    Stern M, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 26762681.
  • 41
    Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Br Med J 2006; 332: 7378.
  • 42
    Girman CJ, Dekker JM, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM et al. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study. Am J Epidemiol 2005; 162: 438447.
  • 43
    Zethelius B, Lithell H, Hales CN, Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year-old men using the euglycaemic insulin clamp. Diabetologia 2005; 48: 862867.